Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
treatment decrease » treatment decreases (Expand search), treatment increase (Expand search), treatment increases (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease or » decrease of (Expand search), decrease on (Expand search), decrease toc (Expand search)
or decrease » not decrease (Expand search), to decrease (Expand search), _ decrease (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
treatment decrease » treatment decreases (Expand search), treatment increase (Expand search), treatment increases (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease or » decrease of (Expand search), decrease on (Expand search), decrease toc (Expand search)
or decrease » not decrease (Expand search), to decrease (Expand search), _ decrease (Expand search)
1
“... response was observed after LPS treatment and the addition of RESV led to decreases in expression of the...”
Access document
Access document
Article
2
4
6
“... of 50.02% (UV) and 42.14% (visible). After 5 cycles of reuse, there was a decrease of about 5% for dry...”
Access document
Access document
Article
7
“... anxiety parameters. Zinc treatment was able to prevent sickness behavior in LPS-exposed rats after the...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
8
9
“...Oral mucositis is one of the most common collateral effects in patients undergoing treatment with...”
Access document
Access document
Doctoral thesis
10
“...Oral mucositis is one of the most common collateral effects in patients undergoing treatment with...”
Access document
Access document
Doctoral thesis
11
12
13
14
15
“... that decrease the toxicity to normal cells and increase the success rates of treatment. The use of beta...”
Access document
Access document
Master thesis
16
17
18
“...-2 an agent involved in the inflammation processes after activation of macrophages by lipopolysaccharide (LPS...”
Access document
Access document
Master thesis
19
“... by compromising sensitive, motor and autonomic fibers, causing a decrease or absence of sensitivity, paralysis and...”
Access document
Access document
Master thesis
20